Flonase Sensimist FDA Approval History
FDA Approved: Yes (First approved August 2, 2016)
Brand name: Flonase Sensimist
Generic name: fluticasone furoate
Dosage form: Nasal Spray
Company: GlaxoSmithKline Consumer Healthcare LP
Treatment for: Allergic Rhinitis
Flonase Sensimist (fluticasone furoate) is an over-the-counter corticosteroid nasal spray indicated for the treatment of symptoms associated with seasonal and perennial allergies in adults and children ages 2 years and older.
Flonase Sensimist is administered via the nostrils once daily for 24-hour relief of both nose- and eye-related allergy symptoms such as itchy, watery eyes, nasal congestion, runny nose, itchy nose and sneezing.
Flonase Sensimist was previously available by prescription as Veramyst.
Development timeline for Flonase Sensimist
| Date | Article |
|---|---|
| Aug 2, 2016 | Approval FDA Approves Flonase Sensimist Allergy Relief |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
